Stay updated with breaking news from Combined Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Totality of data from these ongoing studies suggest clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Phase 1/2a ADMIRAL Study Data STK-001 (70mg): Patients treated with 2 or 3 ini...
New subgroup analyses presented at Digestive Disease Week (DDW) 2022 on the integrated efficacy results of Phase 2b and Phase 3 clinical studies of RBX2660. Data adds to the growing body
Discover key biological insights into risk prediction and breast cancer prevention using population-based proteogenomics
Discover key biological insights into risk prediction and breast cancer prevention using population-based proteogenomics